These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 22809399)
1. Influence of gelatinase B polymorphic variants and its serum levels in atherosclerosis. Spurthi KM; Galimudi RK; Srilatha G; Sahu SK; Nallari P; Hanumanth SR Genet Test Mol Biomarkers; 2012 Aug; 16(8):850-4. PubMed ID: 22809399 [TBL] [Abstract][Full Text] [Related]
2. Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease. Opstad TB; Pettersen AA; Weiss TW; Akra S; Øvstebø R; Arnesen H; Seljeflot I Clin Chim Acta; 2012 Jan; 413(1-2):113-20. PubMed ID: 21963461 [TBL] [Abstract][Full Text] [Related]
3. MMP-9 1562C>T Gene Polymorphism and Efficacy of Glucocorticoid Therapy in Idiopathic Pulmonary Fibrosis Patients. Zhang HT; Fang SC; Wang CY; Wang W; Wu J; Wang C; Xu B; Zhang YM Genet Test Mol Biomarkers; 2015 Nov; 19(11):591-7. PubMed ID: 26401883 [TBL] [Abstract][Full Text] [Related]
4. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina. Kim JS; Park HY; Kwon JH; Im EK; Choi DH; Jang YS; Cho SY Yonsei Med J; 2002 Aug; 43(4):473-81. PubMed ID: 12205736 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress. Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694 [TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the Chinese Han population: a case-control study. Wu HD; Bai X; Chen DM; Cao HY; Qin L Genet Test Mol Biomarkers; 2013 Sep; 17(9):707-12. PubMed ID: 23819814 [TBL] [Abstract][Full Text] [Related]
8. A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers. Singh K; Agrawal NK; Gupta SK; Singh K Int J Low Extrem Wounds; 2013 Sep; 12(3):199-204. PubMed ID: 24043671 [TBL] [Abstract][Full Text] [Related]
9. [The C(-1562)T polymorphism in the promoter of the matrix metalloproteinase-9 (MMP-9) gene and coronary atherosclerosis]. Goracy J; Goracy I; Brykczyński M; Peregud-Pogorzelska M; Naruszewicz M; Ciechanowicz A Pol Arch Med Wewn; 2003 Nov; 110(5):1275-81. PubMed ID: 16736997 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects. Demacq C; de Souza AP; Machado AA; Gerlach RF; Tanus-Santos JE Clin Chim Acta; 2006 Mar; 365(1-2):183-7. PubMed ID: 16168399 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase -9 polymorphism and outcome after acute myocardial infarction. El-Aziz TAA; Mohamed RH Int J Cardiol; 2017 Jan; 227():524-528. PubMed ID: 27825726 [TBL] [Abstract][Full Text] [Related]
12. Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan. Lien LM; Hsieh YC; Bai CH; Chen WH; Chiu HC; Hsieh FI; Shyu KG; Chiou HY; Hsu CY Atherosclerosis; 2010 Oct; 212(2):595-600. PubMed ID: 20609440 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion. Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112 [TBL] [Abstract][Full Text] [Related]
14. The Relationship Between MMP-2 -1306C>T and MMP-9 -1562C>T Polymorphisms and the Risk and Prognosis of T-Cell Acute Lymphoblastic Leukemia in a Chinese Population: A Case-Control Study. Lin CM; Zeng YL; Xiao M; Mei XQ; Shen LY; Guo MX; Lin ZY; Liu QF; Yang T Cell Physiol Biochem; 2017; 42(4):1458-1468. PubMed ID: 28719899 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus. Wang Y; Su Y; Xu Y; Pan SH; Liu GD Biochem Biophys Res Commun; 2010 Jan; 391(1):113-7. PubMed ID: 19909726 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis B and C viruses. El Samanoudy A; Monir R; Badawy A; Ibrahim L; Farag K; El Baz S; Alenizi D; Alenezy A Genet Mol Res; 2014 Sep; 13(3):8025-34. PubMed ID: 25299117 [TBL] [Abstract][Full Text] [Related]
17. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868 [TBL] [Abstract][Full Text] [Related]
18. Serum MMP-9 is elevated in children with asthma. Hong Z; Lin YM; Qin X; Peng JL Mol Med Rep; 2012 Feb; 5(2):462-4. PubMed ID: 22052126 [TBL] [Abstract][Full Text] [Related]
19. Functional polymorphisms in the matrix metalloproteinase-9 gene in relation to severity of chronic periodontitis. Holla LI; Fassmann A; Muzík J; Vanek J; Vasku A J Periodontol; 2006 Nov; 77(11):1850-5. PubMed ID: 17076610 [TBL] [Abstract][Full Text] [Related]
20. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease. Brunner S; Kim JO; Methe H Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]